125 related articles for article (PubMed ID: 26541303)
21. Core-Cone Structured Monodispersed Mesoporous Silica Nanoparticles with Ultra-large Cavity for Protein Delivery.
Xu C; Yu M; Noonan O; Zhang J; Song H; Zhang H; Lei C; Niu Y; Huang X; Yang Y; Yu C
Small; 2015 Nov; 11(44):5949-55. PubMed ID: 26426420
[TBL] [Abstract][Full Text] [Related]
22. EpCAM antibody-conjugated mesoporous silica nanoparticles to enhance the anticancer efficacy of carboplatin in retinoblastoma.
Qu W; Meng B; Yu Y; Wang S
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():646-651. PubMed ID: 28482574
[TBL] [Abstract][Full Text] [Related]
23. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery.
Zhang J; Wu D; Li MF; Feng J
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26666-73. PubMed ID: 26553405
[TBL] [Abstract][Full Text] [Related]
25. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
26. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.
Quan G; Pan X; Wang Z; Wu Q; Li G; Dian L; Chen B; Wu C
J Nanobiotechnology; 2015 Feb; 13():7. PubMed ID: 25643602
[TBL] [Abstract][Full Text] [Related]
27. Folic acid-conjugated mesoporous silica nanoparticles for enhanced therapeutic efficacy of topotecan in retina cancers.
Qu W; Meng B; Yu Y; Wang S
Int J Nanomedicine; 2018; 13():4379-4389. PubMed ID: 30100721
[TBL] [Abstract][Full Text] [Related]
28. Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups.
Ekkapongpisit M; Giovia A; Follo C; Caputo G; Isidoro C
Int J Nanomedicine; 2012; 7():4147-58. PubMed ID: 22904626
[TBL] [Abstract][Full Text] [Related]
29. A general strategy for dual-triggered combined tumor therapy based on template semi-graphitized mesoporous silica nanoparticles.
Wang Y; Wang K; Yan X; Huang R
Adv Healthc Mater; 2014 Apr; 3(4):485-9. PubMed ID: 23997032
[TBL] [Abstract][Full Text] [Related]
30. Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
Lin CH; Cheng SH; Liao WN; Wei PR; Sung PJ; Weng CF; Lee CH
Int J Pharm; 2012 Jun; 429(1-2):138-47. PubMed ID: 22465413
[TBL] [Abstract][Full Text] [Related]
31. A biodegradable pH and glutathione dual-triggered drug delivery system based on mesoporous silica, carboxymethyl chitosan and oxidized pullulan.
Rui Q; Gao J; Yin ZZ; Li J; Cai W; Wu D; Kong Y
Int J Biol Macromol; 2023 Jan; 224():1294-1302. PubMed ID: 36306897
[TBL] [Abstract][Full Text] [Related]
32. [Preparation and anti-cancer activity in vitro of curcumin loaded mesoporous silica nanoparticle].
He LL; Gu J
Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(21):4189-93. PubMed ID: 27071254
[TBL] [Abstract][Full Text] [Related]
33. Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process.
Lin Q; Huang Q; Li C; Bao C; Liu Z; Li F; Zhu L
J Am Chem Soc; 2010 Aug; 132(31):10645-7. PubMed ID: 20681684
[TBL] [Abstract][Full Text] [Related]
34. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
[TBL] [Abstract][Full Text] [Related]
35. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.
Brevet D; Gary-Bobo M; Raehm L; Richeter S; Hocine O; Amro K; Loock B; Couleaud P; Frochot C; Morère A; Maillard P; Garcia M; Durand JO
Chem Commun (Camb); 2009 Mar; (12):1475-7. PubMed ID: 19277361
[TBL] [Abstract][Full Text] [Related]
36. Dendritic Mesoporous Silica Nanoparticles for pH-Stimuli-Responsive Drug Delivery of TNF-Alpha.
Kienzle A; Kurch S; Schlöder J; Berges C; Ose R; Schupp J; Tuettenberg A; Weiss H; Schultze J; Winzen S; Schinnerer M; Koynov K; Mezger M; Haass NK; Tremel W; Jonuleit H
Adv Healthc Mater; 2017 Jul; 6(13):. PubMed ID: 28557249
[TBL] [Abstract][Full Text] [Related]
37. Bi2S3-embedded mesoporous silica nanoparticles for efficient drug delivery and interstitial radiotherapy sensitization.
Ma M; Huang Y; Chen H; Jia X; Wang S; Wang Z; Shi J
Biomaterials; 2015 Jan; 37():447-55. PubMed ID: 25453972
[TBL] [Abstract][Full Text] [Related]
38. Luminescent GdVO4:Eu3+ functionalized mesoporous silica nanoparticles for magnetic resonance imaging and drug delivery.
Huang S; Cheng Z; Ma P; Kang X; Dai Y; Lin J
Dalton Trans; 2013 May; 42(18):6523-30. PubMed ID: 23474744
[TBL] [Abstract][Full Text] [Related]
39. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
40. Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.
Wang Y; Liu P; Duan Y; Yin X; Wang Q; Liu X; Wang X; Zhou J; Wang W; Qiu L; Di W
Biomaterials; 2014 Jan; 35(3):983-92. PubMed ID: 24176193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
